Article

Efficacy and safety of cyclosporine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis

2021-07-05

Abstract excerpt

<h4>Introduction</h4> Cyclosporine may improve the clinical course and outcomes of Coronavirus disease 2019 (COVID-19) due to its antiviral and anti-cytokine effects as shown in vitro. A few ongoing trials are exploring the benefit of adding it to the standard of care (SOC) of COVID-19 patients. <h4>Objectives</h4> The primary objective is to evaluate the severity of COVID-19, determined by oxygen saturation, inte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a2e2516f-328c-54db-962f-53b732943063
DOI: 10.1101/2021.07.03.21259959

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest

Efficacy and safety of cyclosporine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysisDOI 10.1101/2021.07.03.21259959Read

Comparative Effectiveness and Safety of 32 Pharmacological Interventions Recommended by Guidelines for COVID-19: A Systematic Review and Network Meta-Analysis Combining 66 TrialsSemantic proximity Read

Clinical Characteristics and Outcome of Coronavirus Disease 2019 Infection in Patients with Solid Organ Transplants: A Systematic Review and Meta-AnalysisSemantic proximity Read

Kidney Allograft Recipients Diagnosed with Coronavirus Disease-2019: A Single Center ReportSemantic proximity Read

The efficacy and safety of Favipiravir in treatment of COVID-19: A systematic review and meta-analysis of clinical trialsSemantic proximity Read

Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort StudySemantic proximity Read

Effect of Maraviroc and/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: clinical trialSemantic proximity Read

Efficacy and safety of three passive immunotherapies for Corona Virus Disease 2019：a system review and network meta-analysisSemantic proximity Read

Paxlovid for Treating Hospitalized COVID-19 Patients with Kidney InjurySemantic proximity Read

Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell lineSemantic proximity Read

Effective treatment with Tocilizumab in a COVID-19 patient on maintenance hemodialysis: A case reportSemantic proximity Read